Blinatumomab consolidation in children with high-risk first-relapse B-cell precursor acute lymphoblastic leukemia: final 5-year follow-up analysis of a randomized multicenter phase 3 study.

Locatelli F; Rizzari C; Gruhn B; Klingebiel T; Parasole R; Linderkamp C; Flotho C; Petit A; Micalizzi C; Eckert C; Möricke A; Sartor M; Hrusak O; Peters C; Saha V; Vinti L; Desai R; Henry M; Zugmaier G; von Stackelberg A

doi:10.1038/s41375-025-02800-6

← 뒤로

Blinatumomab consolidation in children with high-risk first-relapse B-cell precursor acute lymphoblastic leukemia: final 5-year follow-up analysis of a randomized multicenter phase 3 study.

0/5 보강

Leukemia 📖 저널 OA 57.1% 2025~2026 2026 Vol.40(1) p. 230-234 OA

Locatelli F, Rizzari C, Gruhn B, Klingebiel T, Parasole R, Linderkamp C, Flotho C, Petit A, Micalizzi C, Eckert C, Möricke A, Sartor M, Hrusak O, Peters C, Saha V, Vinti L, Desai R, Henry M, Zugmaier G, von Stackelberg A

📖 무료 전문 🟢 PMC 전문 PMC12789001 🔓 OA PDF unpaywall · cc-by

PubMed ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

↓ .bib ↓ .ris

APA Locatelli F, Rizzari C, et al. (2026). Blinatumomab consolidation in children with high-risk first-relapse B-cell precursor acute lymphoblastic leukemia: final 5-year follow-up analysis of a randomized multicenter phase 3 study.. Leukemia, 40(1), 230-234. https://doi.org/10.1038/s41375-025-02800-6

MLA Locatelli F, et al.. "Blinatumomab consolidation in children with high-risk first-relapse B-cell precursor acute lymphoblastic leukemia: final 5-year follow-up analysis of a randomized multicenter phase 3 study.." Leukemia, vol. 40, no. 1, 2026, pp. 230-234.

PMID 41233549 ↗

DOI 10.1038/s41375-025-02800-6

같은 제1저자의 인용 많은 논문 (1)

Improved outcomes of the refined risk-stratification and risk-adapted therapy in children with acute myeloid leukemia: final results of the AIEOP AML 2013.
Journal of hematology & oncology 2026